{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:16:45Z","timestamp":1778505405816,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","aaojournal.org","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ophtha.2018.04.039","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T11:28:12Z","timestamp":1530617292000},"page":"1776-1783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy"],"prefix":"10.1016","volume":"125","author":[{"given":"Susan B.","family":"Bressler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wesley T.","family":"Beaulieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam R.","family":"Glassman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey G.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Melia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0760-925X","authenticated-orcid":false,"given":"Eric","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Pavlica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee M.","family":"Jampol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ophtha.2018.04.039_bib1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJM199908263410907","article-title":"Treatment of diabetic retinopathy","volume":"341","author":"Ferris","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ophtha.2018.04.039_bib2","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jamaophthalmol.2013.4154","article-title":"Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial","volume":"131","author":"Bressler","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"10.1016\/j.ophtha.2018.04.039_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2006.05.064","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ophtha.2018.04.039_bib4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ophtha.2016.12.005","article-title":"Diabetic Retinopathy Clinical Research Network. Factors associated with worsening proliferative diabetic retinopathy in eyes treated with panretinal photocoagulation or ranibizumab","volume":"124","author":"Bressler","year":"2017","journal-title":"Ophthalmology"},{"issue":"10085","key":"10.1016\/j.ophtha.2018.04.039_bib5","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(17)31193-5","volume":"389","author":"Sivaprasad","year":"2017","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ophtha.2018.04.039_bib6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/jamaophthalmol.2017.1652","article-title":"Results of a randomized clinical trial of aflibercept vs panretinal photocoagulation for proliferative diabetic retinopathy: Is it time to retire your laser?","volume":"135","author":"Glassman","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"20","key":"10.1016\/j.ophtha.2018.04.039_bib7","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/jama.2015.15217","article-title":"Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial","volume":"314","author":"Gross","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ophtha.2018.04.039_bib8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0002-9394(02)01825-1","article-title":"A\u00a0computerized method of visual acuity testing: adaptation of the Early Treatment of Diabetic Retinopathy Study testing protocol","volume":"135","author":"Beck","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"0","key":"10.1016\/j.ophtha.2018.04.039_bib9","article-title":"Should multiple imputation be the method of choice for handling missing data in randomized trials?","volume":"0","author":"Sullivan","year":"2016","journal-title":"Stat Methods Med Res"},{"issue":"10","key":"10.1016\/j.ophtha.2018.04.039_bib10","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.ophtha.2007.06.047","article-title":"Visual acuity as an outcome measure in clinical trials of retinal diseases","volume":"114","author":"Beck","year":"2007","journal-title":"Ophthalmology"},{"issue":"5 Suppl","key":"10.1016\/j.ophtha.2018.04.039_bib11","first-page":"786","article-title":"Grading diabetic retinopathy from stereoscopic color fundus photographs\u2013an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group","volume":"98","year":"1991","journal-title":"Ophthalmology"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642018305773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642018305773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T03:13:01Z","timestamp":1539227581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642018305773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0161642018305773"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2018.04.039","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2018.04.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}